# Levothyroxine Sodium

NDC: 0904-6951
Generic name: Levothyroxine Sodium
Labeler / Manufacturer: Major Pharmaceuticals
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20190320

FDA application: ANDA209713

## Active ingredients

- LEVOTHYROXINE SODIUM: .075 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0904-6951"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0904-6951
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=333642fd-93ae-4dc0-9c83-6d6b163c1c74